EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis

Alise K Carlson, Robert J Fox

Neurologic Clinics · 2024

DOI: 10.1016/j.ncl.2023.07.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurologic Clinics, 2024. Verfasst von Alise K Carlson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Mellen Center, 9500 Euclid Avenue U10, Cleveland, OH 44195, USA. Hauptthemen laut MEDLINE: Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Biogen, National Multiple Sclerosis Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

More than one million individuals are impacted by progressive forms of multiple sclerosis. The literature examining the management of MS has focused primarily on relapsing forms of disease, and effective therapies targeting progressive mechanisms in MS remains a significant unmet need. Despite this, there are several encouraging potential therapeutics on the horizon. Improved understanding of mechanisms underlying MS progression, identification and validation of biomarkers, identification of novel therapeutic targets, and improved trial design are needed to further propel progress in the management of individuals with progressive forms of MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisMultiple Sclerosis, Chronic ProgressiveHumansRecurrenceBiomarkersDisease Progression

Stichwörter der Autor:innen

Multiple sclerosisPrimary progressive multiple sclerosisProgressionProgressive multiple sclerosisSecondary progressive multiple sclerosis

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Cleveland Clinic Mellen Center, 9500 Euclid Avenue U10, Cleveland, OH 44195, USA.
  • Cleveland Clinic Mellen Center, 9500 Euclid Avenue U10, Cleveland, OH 44195, USA. Electronic address: foxr@ccf.org.

Förderung

  • Biogen
  • National Multiple Sclerosis Society

Zitieren

APA

Carlson, A. K., & Fox, R. J. (2024). Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis. Neurologic Clinics. https://doi.org/10.1016/j.ncl.2023.07.002

Vancouver

Carlson AK, Fox RJ. Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis. Neurologic Clinics. 2024. doi:10.1016/j.ncl.2023.07.002

BibTeX
@article{Carlson2024,
  author = {Carlson, Alise K and Fox, Robert J},
  title = {Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis},
  journal = {Neurologic Clinics},
  year = {2024},
  doi = {10.1016/j.ncl.2023.07.002}
}
Kostenlos starten →